The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly ...

For $45 million upfront, Vor Bio is gaining ex-China rights to RemeGen’s telitacicept, a first-in-class recombinant ...

Robert F. Kennedy Jr.’s vaccine advisory committee recommended Merck & Co.’s shot to prevent newborns from getting RSV, ...

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory ...

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will ...

AstraZeneca Share Price – Track LIVE BSE/NSE stock prices of AstraZeneca with insights on performance, fundamentals, market cap, shareholding, financials, company profile, balance sheet, annual and ...

Astrazeneca Pharma India is trading-1.16% lower at Rs 8,762.50 as compared to its last closing price. Astrazeneca Pharma India has been trading in the price range of 8,866.45 & 8,705.20 .

The ECB should abandon targeting headline inflation and focus instead on price growth in discretionary spending to protect ...

Masayoshi Son acknowledged the outlines of a succession plan, addressing what may be the single biggest concern among ...

Law Offices of Howard G. Smith reminds investors of the upcoming August 12, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Tempus AI, Inc.